Many asthmatic patients have significant nasal problems and proper management requires treatment of both the upper and the lower airway disease. Abstract 9 shows that a pharmacist can improve the management of a chronic condition like asthma in an HMO setting. Abstract 10 shows the benefit of an asthma education program. Abstract 11 indicates that long-term use of inhaled corticosteroids is not totally free of risk. Post-menopausal women, already risk for osteoporosis, may when on steroids get loss of bone mineral density.
Risk is related to dose.
There were no sigiificant differences between treatment groups in change from baseline AM PEF values or in FEV as a percent of predieted at month l2. There were no significant differences between the treatment groups at month 12 in daily beta-agonist use or sleep disturbance. 1 EF Juniper, et al. AEs were generally mild or moderate in intensity with no differences between treatments. Improves Pulmonary Function and Symptoms in Children with Inhaled Steroid-Dependent Asthma.